GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
40 hedge funds and large institutions have $14.2M invested in Aevi Genomic Medicine Inc in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
40
Holding in Top 10
–
Calls
$33K
Puts
–
Top Buyers
| 1 | +$233K | |
| 2 | +$43.8K | |
| 3 | +$36.9K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.4K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$22K |
Top Sellers
| 1 | -$964K | |
| 2 | -$203K | |
| 3 | -$63K | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$43.1K |
| 5 |
Renaissance Technologies
New York
|
-$32.5K |